Roman Butler Fullerton & CO Edwards Lifesciences Corp Transaction History

Roman Butler Fullerton & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$81.41 - $94.33 $24,423 - $28,299	-300 Reduced 11.9%	2,220 $209,000
Q1 2023 Apr 27, 2023	BUY	$74.26 - $84.51 $187,135 - $212,965	2,520 New	2,520 $208,000
Q3 2020 Oct 15, 2020	BUY	$67.19 - $87.44 $169,318 - $220,348	2,520 New	2,520 $201,000
Q1 2020 Apr 13, 2020	SELL	$52.41 - $81.0 $55,554 - $85,860	-1,060 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$71.7 - $82.09 $76,002 - $87,015	1,060 New	1,060 $247,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Roman Butler Fullerton & CO, based on Form 13F filings with the SEC.

Stay updated on Roman Butler Fullerton & CO with notifications on news.